0000950170-24-071516.txt : 20240610
0000950170-24-071516.hdr.sgml : 20240610
20240610193054
ACCESSION NUMBER: 0000950170-24-071516
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240610
DATE AS OF CHANGE: 20240610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Encrantz Staffan
CENTRAL INDEX KEY: 0001870875
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40587
FILM NUMBER: 241034303
MAIL ADDRESS:
STREET 1: C/O SIGHT SCIENCES, INC.
STREET 2: 4040 CAMPBELL AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sight Sciences, Inc.
CENTRAL INDEX KEY: 0001531177
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 800625749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4040 CAMPBELL AVE,
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (415) 889-0550
MAIL ADDRESS:
STREET 1: 4040 CAMPBELL AVE,
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
ownership.xml
4
X0508
4
2024-06-06
0001531177
Sight Sciences, Inc.
SGHT
0001870875
Encrantz Staffan
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100
MENLO PARK
CA
94025
true
false
false
false
false
Common Stock
2024-06-06
4
A
false
17366
0.00
A
1029516
D
Common Stock
1184258
I
See footnote
Common Stock
4022118
I
See footnote
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
Includes (i) 1,012,150 shares of Common Stock and (ii) 17,366 RSUs, which are subject to vesting as reported herein.
These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.
These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President of Allegro Investment Inc., the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund. The Reporting Person disclaims beneficial ownership of the shares held by Allegro Investment Fund (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.
/s/ Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz
2024-06-10